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ABSTRACT 
Aim. To explore specialist and generalist palliative care provision for people with non-
malignant respiratory disease, in rural and urban areas in the North and Republic of Ireland. 
Background. Globally, palliative care is recommended as an appropriate healthcare 
option for people with advanced non- malignant lung disease. Yet, there is limited evidence 
regarding the integration of palliative care for this client group. 
Design. Qualitative study. 
Methods. Convenience sample of 17 bereaved carers and 18 healthcare professionals 
recruited from two rural and two urban sites on the Island of Ireland. Data were collected 
throughout 2012 and 2013 through semi-structured interviews with carers of patients with 
Chronic Obstructive Pulmonary Disease (N=12), interstitial lung disease (N=4) or 
bronchiectasis (N=1) who had died 3-18 months previously; and 4 focus groups with 
healthcare professionals. Data were analysed using a thematic analysis framework. 
Results. Carers’ interviews yielded three overarching themes:1) Lack of preparedness for 
death, due to ambiguity regarding disease trajectory; 2) Lack of consistency in palliative care 
delivery, in relation to the receipt of generalist and specialist palliative care; and 3) Role 
ambiguity, related to their caregiving role. Focus groups identified two overarching themes:1) 
Barriers to appropriate palliative care; and 2) The future direction of palliative care for patient 
with non-malignant respiratory disease. 
Conclusion. The uncertain disease trajectory was not only experienced by carers but also 
healthcare professionals. Although referral to specialist palliative care services was perceived 
as increasing, the availability and coordination of generalist and specialist palliative care 
services were fragmented and varied dependent on geographical location. 
Keywords 
non-malignant respiratory disease, COPD, chronic obstructive pulmonary disease, 
bronchiectasis, interstitial lung disease, palliative care, family carers, qualitative research, 
nursing and healthcare professionals 
Summary Statement 
Why is this research needed? 
         Internationally, palliative care is recommended for people with non- malignant 
respiratory disease, yet the integration of palliative care for this client group is 
unclear. 
         There is limited evidence regarding palliative care for patients with interstitial lung 
disease or Bronchiectasis, alongside Chronic Obstructive Pulmonary Disease. 
         There is limited research regarding the influence of geographical location on the 
provision of palliative care for patients with non- malignant respiratory disease. 
 What are the key findings? 
         The uncertain disease trajectory associated with non- malignant respiratory disease 
and a lack of prognostic information from healthcare professionals, resulted in a lack 
of preparedness for death. 
        The availability and coordination of generalist and specialist palliative care services 
were fragmented and varied dependent on geographical location, this was not just 
isolated to rurality but also health jurisdiction. 
         Specialist and generalist palliative care services are appropriate for patients with 
other forms of non- malignant respiratory disease such as bronchiectasis 
and interstitial lung disease, not just Chronic Obstructive Pulmonary Disease. 
  How should the findings be used to influence policy/practice/research/education? 
         Future respiratory and palliative care policies should reinforce amongst healthcare 
professionals the importance of providing information regarding prognosis to this 
client group and be effectively implemented in clinical practice. 
         Enhanced access to specialist and generalist palliative care services is needed in areas 
with fewer services to improve local palliative service provision. 
         Palliative service provision should be inclusive of all forms of non-malignant 
respiratory disease to address the needs of patients with interstitial lung disease and 
bronchiectasis, alongside Chronic Obstructive Pulmonary Disease. 
 Introduction 
Non- Malignant Respiratory Disease (NMRD) is an umbrella term that includes Interstitial 
Lung Disease (ILD), bronchiectasis and Chronic Obstructive Pulmonary Disease (COPD) 
(National End of Life Care Intelligence Network 2011). Over 200 million people worldwide 
have a diagnosis of COPD and while confirmability data are not available, it is estimated that 
the extent of other chronic respiratory diseases is a growing global health problem (World 
Health Organisation (WHO) 2008). International guidelines emphasise the importance of 
generalist and specialist palliative care being made available to patients with a respiratory 
illness (Bradley et al. 2008, Lanken et al. 2008, NICE 2010, Raghu et al. 2011, NICE 2013). 
Research suggests however that patients with NMRD do not receive the same standards of 
palliative care as patients with lung cancer (Goodridge et al. 2008, Partridge et al. 2009). 
  
Background 
In 2014, the WHO and the Worldwide Palliative Care Alliance (WPCA) published an atlas 
highlighting the global need for palliative care. This atlas highlighted that although palliative 
care programs have mainly focused on the needs of people with a malignant disease in the 
past, the majority of those worldwide needing palliative care have a non-malignant diagnosis. 
A key recommendation from the WHO and WPCA was that palliative care should be 
integrated into relevant national health and disease-specific policies, a concept mirrored in 
the Palliative Care 2020 (2014) European Declaration on Palliative Care. Palliative Care 
2020 additionally declared that new policies specific to palliative care must include referral 
criteria to facilitate timely access to palliative care based on the persons holistic needs, 
regardless of diagnosis or prognosis. 
  
There is clear symptom burden experienced by patients with NMRD, such as dyspnoea, 
hypercapnia and anxiety, therefore palliative care may mitigate against increased burden by 
the judicious use of analgesics, antibiotics, O2 therapy and comfort care measures as 
appropriate. Generalist and specialist palliative service provision for patients with NMRD in 
the North and Republic of Ireland (ROI) has been previously described (Mc Veigh et 
al. 2017). In NI, patients with COPD and their carers expressed concerns about a variety of 
unmet holistic needs (Hasson et al. 2008). Hasson et al. additionally highlighted that patients 
with COPD experienced uncertainty regarding the trajectory of their disease. Further 
evidence also depicted that carers of patients with COPD had a range of unmet needs and can 
receive inadequate support from the healthcare profession (Spence et al. 2008). There is 
limited evidence however regarding palliative care for patients with ILD or Bronchiectasis, 
alongside COPD. Given this background the research question guiding this study was: What 
are the perceptions of bereaved carers and healthcare professionals (HCPs) of the generalist 
and specialist palliative care service provision for people with NMRD, in rural and urban 
areas in the North and ROI. 
  
The study 
Aim 
The aim of this study was to explore specialist and generalist palliative care provision for 
people with NMRD from the perspectives of bereaved family carers and healthcare staff, in 
rural and urban areas in the North and ROI. 
  
Design 
This study employed a broad interpretivist qualitative enquiry to facilitate an in-depth 
exploration of the intricacies of the topic being investigated and to appropriately access the 
meanings and values study participants applied to their experiences (Lapan et al. 2011). 
  
Participants 
Recruitment for the interviews and focus groups has been previously highlighted (Mc 
Veigh et al. 2017). Convenience sampling was employed in this study. Sociodemographic 
details about participants of the interviews and focus groups are conveyed in Table 1. All 
participants were recruited across two rural and two urban sites in the NI and the ROI 
(Figures 1 & 2). Eligible participants targeted for the semi-structured interviews were 
bereaved family carers, identified by a respiratory nurse specialist as the main carer, of 
people with NMRD who had died three to eighteen months previously. Participants were 
excluded if they were under 18 years old, did not speak English or were too distressed to take 
part in a research study. Eligible participants for the focus groups included members of the 
multi-disciplinary team that were involved in the generalist and specialist palliative care of 
patients with NMRD and identified by relevant heads of each department. 
  
Data Collection 
Data were collected throughout 2012 and 2013. Semi-structured interviews with caregivers 
(see supplementary information table 1) were conducted in participants’ homes (N=10), or 
over the telephone (N=7) to allow them to choose an interview method that was most 
convenient. Interviews ranged from 22 – 80 minutes in length, with an average of 50 minutes. 
Focus groups (n=4) with HCPs were conducted at each site involved in the study (see 
supplementary information Table 2). The focus groups ranged from 68 – 81 minutes in 
length, with an average of 74 minutes. All interviews and focus groups were digitally 
recorded and transcribed verbatim. Interviews and focus groups were conducted by the lead 
author who had appropriate training on conducting qualitative research. To aid accurate 
recording of focus groups, an additional member of the research team fulfilled the role of 
note taker. Data collection was completed when it was noted by the researcher that no new 
themes or information were emerging from the data. 
  
Data Analysis 
Data were analysed by adopting a thematic analysis framework described by King & 
Horrocks (2010). To assist with managing the data the qualitative research software package 
NVivo (Jupp 2006) was used to provide the tools to support the management and 
categorisation of the qualitative data. Stage one of analysis was the assignment of descriptive 
themes to sections of the data to describe their meaning. Stage two encompassed grouping 
together descriptive themes to generate interpretative themes and highlight emerging patterns 
in the data. The third stage of the framework required the identification of a number of 
overarching themes developed by pulling together and linking all the interpretative themes 
that had been established. The overarching and interpretative themes are outlined 
in supplementary information Table 3. 
   
Ethical considerations 
The ethical considerations of the study have been previously described (Mc Veigh et 
al. 2014). Ethical approval was received from the Officeof Research and Ethics Committee 
NI (ORECNI, Reference: 11/NI/0166) and governance permission from the Northern Health 
and Social Care Trust (Reference: NRP11-0264/09), Belfast Health and Social Care Trust 
(Reference:11080JR-AS), Letterkenny and Dublin. Written and verbal informed consent was 
obtained at the time of interview or focus group. 
  
Rigour 
Rigour of the study has been described previously (Mc Veigh et al. 2014). Each transcription 
was initially analysed by the lead author and then reviewed by the remaining research team to 
verify the themes generated from the data collected. 
  
Findings 
Quotes are used as best exemplars from each theme. The anonymous participant codes and 
transcript page numbers for each quote are also included. 
 
 
  
Semi-structured Interviews Findings 
Analysis of the carers’ interviews identified three key overarching themes: 1) lack of 
preparedness for death; 2) lack of consistency in palliative care delivery; and 3) role 
ambiguity. 
Overarching theme 1) Lack of preparedness for death 
Participants expressed feelings of ambiguity in relation to the life limiting nature of NMRD 
due to unpredictable disease trajectory. The unpredictable nature of ILD, explained by a carer 
of a patient with idiopathic pulmonary fibrosis (IPF), highlighted how quickly the patient’s 
condition progressed and recalled their shock at this rapid decline: 
“She deteriorated very quickly when she went into the hospice I have to say. From going in 
and being able to walk and look after herself very quickly it got to the stage where she 
couldn't walk and didn't get dressed or anything. She had gone downhill very rapidly when 
she went home and then went back into the hospice.” (BC4, p5). 
  
Carers of patients with COPD or Bronchiectasis expressed that the patient’s condition 
appeared to deteriorate and then improve, leading them to believe that the patient would 
always get better again after becoming unwell: 
You know a few Christmases ago he was rushed into hospital on Christmas Eve and 
was really unwell and I saw the wires and everything and thought this is serious. But 
he pulled through. So it was a case of every time he went into hospital the whole 
village just thought, ‘aw there he goes back into hospital again he will be out by the 
weekend.’ So we never expected him to die, to not come home. Nobody expected it at 
all, my friends, nobody. (BC9, p4). 
  
Carers additionally highlighted feelings of uncertainty about the patient’s condition 
associated with a lack of information from HCPs about the life-limiting nature of NMRD: 
You know nobody ever told me how long he had left or how long this was going to go 
on for and I feel now I could have done with more information. Nobody ever tells 
you, you are just left to your own imagination and they just expect you to know but 
people don’t know. Now I know a doctor can’t just turn around and tell you the exact 
date he is going to last too but they could have given me an indication that he wasn’t 
going to get better and that it would only go on so long. They are bound to know by 
the symptoms how long it is likely to go on for. (BC14, p7). 
  
Due to difficulties in gauging how the patient’s condition was going to progress, participants 
were left feeling uncertain about the staging of the patient’s illness. This led to feelings of 
unpreparedness amongst participants when the patient’s condition deteriorated. 
  
Overarching theme 2) Lack of consistency in palliative care delivery 
Carers’ accounts demonstrated a lack of consistency in the timing of palliative care delivered 
to this client group. Carers expressed that specialist palliative care was only introduced when 
the patient was nearing the end of life and felt patients’ could have benefited from it being 
introduced earlier: 
We would have liked to have had more of the [specialist] palliative care side of things 
earlier on rather than just before he died. (BC15, p3). 
  
Inthe ROI, results confirmed that patients with NMRD received adequate support for their 
palliative needs in hospital. However, this care was not continued when the patient was 
discharged back into the community: 
Well we felt that he could have definitely done with more support at home to help 
him. But now when he went into hospital the support he got there was brilliant, the 
respiratory nurses and all were just brilliant. But when he was discharged home the 
care just stopped, it tapered off when he was discharged home from hospital. (BC15, 
p2) 
  
Carers additionally reported that the majority of patients with NMRD in the ROI (n=7) died 
in hospital (n=6), rather than their preferred place of death: 
My partner would have ideally liked to come home but…he did die in hospital. 
(BC16, p13) 
  
In contrast to the views expressed by participants in the ROI, findings highlighted that 
patients with NMRD in NI had sufficient generalist palliative care to deal with their palliative 
needs in the primary care setting: 
As her illness progressed they were there for her. You know and obviously somebody 
was assessing to make sure that was happening. And then they brought in the machine 
for during the night and it was a very noisy machine, so they put that in that it was 
upstairs in the bedroom and also downstairs in the living room and so you could tell 
as the illness progressed all the services were being put in that she needed. (BC4, p4). 
  
However, participants perceived that there was still insufficient palliative care service 
provision experienced at home to facilitate preferred place of death: 
  
She did die in hospital, she did indeed and that’s part of my hurt, calling the 
ambulance and letting her die in there. She would have loved to have died at home. I 
think that if we had have had more support at home she could have died at home. 
(BC1, p10) 
  
Overarching theme 3) Role Ambiguity 
Results illuminated carers’ feelings of ambiguity related to their caregiving role. Participants 
felt confused as to why they were not allowed to be involved in some conversations that took 
place between the patient and the HCP: 
Any of the other doctors didn't mind when I stayed with my husband to explain to him 
what they were saying but she [the doctor] wouldn't let me stay. And it was always, 
'you wait out in the corridor and I will speak to you in a few minutes. (BC3, p4).     
Carers’ expressed that the knowledge they acquired whilst caring for a patient at home was 
not acknowledged in the inpatient setting: 
When I went to refill the machine [non-invasive ventilation machine] with water there 
was a nurse practitioner there and she went through me for touching the machine and 
I was very angry as I knew just as much about operating the bloody machine as she 
did. (BC2, p8) 
  
Role ambiguity was also exemplified by participants’ conclusions that they had a lack of 
support from the healthcare profession and therefore had no choice but to take up the role of 
carer: 
You know it ended up being me and my sister that would have went up a lot to see 
him and help him out because we didn’t have any other support. A lot of the pressure 
was put on ourselves to look after him. (BC15, p3). 
  
Carers additionally revealed that certain HCPs depended on them to provide guidance on how 
to deliver certain elements of care to the patient, such as non-invasive ventilation: 
I went to for a holiday on the Wednesday and I had no sooner arrived than I got a 
phone call saying 'this is the nursing home here something is wrong with the nippy 
machine can you come and fix it?' I then had to spend the next couple of hours 
sending texts to the nippy rep and she actually went to the nursing home to sort it out. 
(BC2, p3) 
  
Focus Group Findings 
Analysis of the HCP focus groups yielded two key overarching themes: 1) barriers to 
providing appropriate palliative care and 2) the future direction of palliative care for patients 
with NMRD.	
   
Overarching theme 1) Barriers to providing appropriate palliative care 
Participants across NI and the ROI described an inability to provide timely palliative care to 
patients with NMRD due to difficulties in identifying the patient’s prognosis. For patients 
with COPD and bronchiectasis, findings indicated that prognostic uncertainty was related to 
the patient having multiple episodes of becoming very unwell and then their condition 
improving: 
With lung cancer patients you can give a rough prognosis and know when to 
introduce palliative care. With patients with COPD there is no definitive timeline and 
they can be up and down so there is no obvious point where you know to definitely 
involve palliative care so that is the big issue really. (RN8, Respiratory Deputy Ward 
Manager, p8). 
  
Healthcare professionals expressed that with a diagnosis of IPF it was easier to identify when 
the patient’s condition was deteriorating: 
Certainly in pulmonary fibrosis (ILD) it is fairly clear as there is a clearly defined 
decline and there is a life expectancy attached to the diagnosis. So I think we are 
better at recognising they are palliative than we were certainly but there are some 
improvements still to be made. (RC2, Respiratory Consultant, p14) 
 However, participants also recognised that an inadequate understanding amongst HCPs of 
the role of palliative care in NMRD created barriers to providing appropriate palliative care: 
Well there are people who won’t refer to palliative care and you will find it has a lot 
to do with their own hang ups about what palliative care really is and their own lack 
of understanding. (PCN5, Palliative Care Nurse Specialist, p7). 
  
Participants in NI held the view that specialist palliative care was available equally to patients 
with COPD, bronchiectasis and ILD. However HCPs in the ROI indicated an inequality in the 
provision of specialist palliative care to patients with ILD or bronchiectasis, comparative to 
those with COPD: 
I suppose from what I have seen it is mostly COPD patients that get seen by specialist 
palliative care and I haven’t had any bronchiectasis patients that have been seen or 
referred to specialist palliative care that I am aware of. (PH, Physiotherapist, p8) 
  
Throughout NI and the ROI, the lack of availability of generalist and specialist palliative care 
services in rural areas to patients with NMRD, in comparison to those in urban settings, was 
highlighted: 
In particular in the really rural areas they are particularly bad spots and we have major 
issues getting packages of care for anywhere around really rural areas. You just cringe 
when you hear someone’s address is there and you just hope that they don’t need a 
package because it is very, very difficult to get one. Even if they are end of life care 
it’s still extremely difficult because the services are just not available. (PCN3, 
Palliative Care Inpatient Unit Deputy Ward Manager, p13). 
  
I think as well with the specialist palliative care services there maybe aren’t as many 
available to NMRD patients in the more rural areas as there are in urban areas. 
(PCN5, Palliative Care Nurse Specialist, p10). 
 Overarching theme 2) The future direction of palliative care for patients with NMRD	
  
Throughout NI and the ROI, HCPs conveyed that the presence of specialist palliative care 
providers in the care of patients with NMRD was increasing: 
The balance has changed because with our post [specialist palliative care OT] about 7 
years ago there would have been the expectation that it would 90:10 malignant versus 
non-malignant disease but it has changed and I would say we are fast approaching a 
75% caseload for malignant and the rest are non-malignant just made up of neurology 
or respiratory. (OT1, Specialist Palliative Care Occupational Therapist, p3). 
  
The increased referrals to specialist palliative care services were perceived as being a result 
of specialist palliative care providers being more accepting of patients who have a non-
malignant diagnosis: 
Now all hospices are open to take non-malignant referrals which are great and they 
are much more eager to fill that role than they were previously. (PCN5, Palliative 
Care Nurse Specialist, p4). 
  
In NI the presence of a regional model to guide the implementation of palliative care, 
dependant on stage of illness, was used by HCPs caring for patients with NMRD to ensure 
they received optimal palliative care: 
Well there is the ELCOS (End of Life Care Operational System) Model for palliative 
care used for respiratory palliative care and that is regional and it moves from early to 
late phase and tells you what the patient should be getting at each stage. And I 
suppose with the model everything is there and you know what’s available and what 
you should be doing and us a team can look and see what we need to be doing. (RN2, 
Respiratory Nurse Specialist, p14) 
  
In the ROI however, participants acknowledged the lack of a regional model for palliative 
care that could help to guide the delivery of care to patients with NMRD: 
We don’t have a model for either delivering palliative care or respiratory care and I 
suppose we should. (RN5, Respiratory Nurse Specialist, p8). 
  
The role of the carer was acknowledged and great emphasis was placed on the importance of 
meeting the carer’s information needs regarding the patient’s condition: 
Carers are slightly different, carers are different from patients. I think that quite often 
the carer has to have a clear picture of what is going on … if you have a carer you 
would often say, you know, ‘It is very, very severe lung disease and they may not 
survive this illness.’ And that is a conversation that I often have very frequently with 
people. The carers are very keen to know how severe their relative is and the relative 
will be told that they have severe lung disease and let them ask what they want to 
know after that. There can be people [patients] who are devastated and don’t want to 
know and yet the relatives have to know a little bit more of the gritty reality of, ‘This 
is really tough stuff here and they are really unwell. (RC1, Respiratory Consultant, 
p21). 
  
The wellbeing of the carer had an impact on the patient’s experience as for patients with 
NMRD to be successfully cared for at home the carer needed adequately supported: 
I think you have to have the carers on board as well because a lot of home 
management systems fail not because of the patient but because of the carer. You 
know trying to get someone home because ‘Transforming Your Care’ [2011 review of 
health and social care in NI] says that more people should have the chance to die at 
home but often it is the carer that you see totally wide eyed with fear when their loved 
one says that they want to go home and they sort of think ‘how do I manage this?’ So 
I think the support to the carer is hugely important, although you focus on the patient 
you have to give just as much support to the carer. (RC2, Respiratory Consultant, 
p22). 
  
DISCUSSION 
Carers’ accounts concurred with previous research as they highlighted how the uncertain 
COPD trajectory resulted in ambiguity regarding disease progression amongst patients and 
carers (Pinnock et al. 2011, Hynes et al. 2012). Similarly, bronchiectasis caused uncertainty 
regarding the disease trajectory due to the patient’s fluctuation between periods of illness and 
wellness. However ILD caused prognostic uncertainty through displaying a trajectory where 
the patient’s condition was perceived as being stable and then rapidly deteriorating after 
experiencing no exacerbations to their condition. Previous research suggested that the 
deterioration in patients with ILD helped patients and carers understand that the condition 
was palliative (Bajwah et al. 2012). Conversely, our study reported that patients with ILD 
and their carers were unprepared for this rapid deterioration and it did not provide further 
clarity into the life-limiting nature of the disease. Carers perceived a lack of awareness 
regarding the patient’s prognosis was also caused by a lack of information from HCPs 
regarding the palliative nature of NMRD. This adds to previous research which has 
highlighted that patients with COPD often get to the stage in their illness where they require 
regular oxygen therapy and are still unaware they have a palliative illness, due to a lack of 
information about the life limiting nature of their disease (Gott et al. 2009, Lowey et 
al. 2013). The present study highlighted a lack of death preparedness (Pincombe et al. 2000) 
amongst not only patients with COPD and their carers, but also those with bronchiectasis and 
ILD. Death preparedness can be defined as the readiness for death (Hebert et al. 2006) 
experienced by the patient and their carer. A contributing factor to being prepared for death is 
also an awareness of dying (Mc Leod-Sordjan 2014), however the present study highlighted 
how, alongside COPD, patients with bronchiectasis and ILD were unaware of the life limiting 
nature of the disease and that the patient would die from the disease. 
  
Findings additionally demonstrated that, alongside carers, HCPs found a lack of prognostic 
certainty in relation to NMRD that resulted in difficulties determining disease 
progression. This aligned with previous research highlighting that prognostic uncertainty 
caused HCPs to experience difficulties in effectively managing patients with advanced COPD 
and recognising when their condition was declining (Spence et al. 2008, Pinnock et al. 2011). 
Our findings further highlighted that this is not isolated to COPD as HCPs perceptions also 
associated prognostication difficulties with bronchiectasis. Conversely findings highlighted 
that, unlike carers, HCPs perceived that it was easier to identify the prognosis of a patient 
with ILD due to clear prognostic indicators. Previous research in the UK (Bajwah et al. 2012) 
appears to align with our findings, highlighting that HCPs may not have provided patients 
with ILD and their carers with appropriate prognostic information. 
  
Inequalities in the provision of palliative care across the island of Ireland can be influenced 
by geographic location (DHSSPSNI 2011, Joint Oireachtas Committee on Health and 
Children 2014, Murray et al. 2013) and was evidenced in the present study. Findings aligned 
with previous research as HCPs perceived that palliative care services were limited for 
patients living in rural areas (Robinson et al. 2009, Goodridge et al. 2010). The present study 
highlighted however that the influence of geographical location on palliative care for NMRD 
was not solely dependent on rurality. Findings concurred with previous research highlighting 
disparities between the availability of generalist and specialist palliative care services in the 
primary care setting across Europe (Lopez-Campos et al. 2014). Our study however 
illuminated perceptions that patients with NMRD in the ROI had limited access to palliative 
care services in the primary care setting, in comparison to NI. Patients with COPD can have 
several readmissions to hospital caused by a lack of follow up care in the community post 
discharge (Jeffs et al. 2014). Present findings additionally highlighted that the lack of 
services in the primary care setting in the ROI for patients with ILD and bronchiectasis, 
alongside COPD, may have influenced their place of death. This demonstrated how patients’ 
geographical location and the palliative care services available in this location, potentially 
had an impact on whether or not they died in their preferred place of care. 
  
Previous research has identified models of palliative care for patients with ILD and COPD, 
advocating the introduction of specialist palliative care early in a patient’s disease trajectory 
(Higginson et al. 2014) or when a patients’ symptom management becomes too complex for 
generalists to manage (Strang et al. 2013). In the present study participants perceived that 
specialist palliative care services were not involved with the majority of patients, concurring 
with previous findings related to patients with ILD (Bajwah et al. 2012, Lindell et al. 2014) 
and COPD (Beernaert et al. 2013). We additionally discovered that patients with 
bronchiectasis also experienced a lack of involvement from specialist palliative care 
providers. Carers’ accounts highlighted that patients with NMRD and their carers wanted 
access to these services however service availability was often uncoordinated and varied. 
Healthcare professionals however perceived that referrals to specialist palliative care for 
patients with NMRD are increasing. Results conveyed that this may be equated to increased 
acceptability of the role of specialist palliative care for patients with non-malignant 
conditions. 
  
Carers referred to feelings of role ambiguity caused when they felt excluded from elements of 
the patients care, but also highlighted how HCPs depended on the carer. Previous research in 
the UK highlighted that carers of patients with COPD felt unprepared for their role and often 
felt isolated, due to a lack of bio-psychosocial support from HCPs (Spence et al. 2008). We 
additionally ascertained that carers of patients with ILD and bronchiectasis, alongside COPD, 
also felt isolated when not included in the delivery of some elements of the patients care, 
especially in the secondary care setting. Healthcare professionals’ perceptions aligned with 
the view that more effective carer assessments are required that would enable the appropriate 
identification of the needs and concerns of carers of patients with NMRD. 
  
These findings have implications for clinical practice, policy and research. A key 
recommendation from regional palliative care guidelines was the timely provision of 
information to patients with a life- limiting illness and their carers regarding their illness 
(DHSSPSNI 2010). However findings demonstrated that the recommendations of these 
palliative and end of life care strategies often may not be implemented by HCPs caring for 
patients with NMRD. Future respiratory and palliative care policies need to reinforce 
amongst HCPs the importance of providing information regarding prognosis and prognostic 
difficulties, to patients with NMRD and be effectively implemented in clinical practice. 
  
The National Respiratory (COPD) Framework (Irish Thoracic Society et al. 2008) recognised 
the need for patients in the ROI with COPD to have access to multidisciplinary teams that 
included specialist palliative care input and this is available in the North and ROI (Murray et 
al. 2013, Belfast Health and Social Care Trust 2015, Northern Health and Social Care Trust 
2015). However the present study and previous evidence (Murray et al. 2013), has 
highlighted that the availability and coordination of these services are fragmented and can be 
varied dependant on geographical location. Enhanced availability of these services would 
afford generalist palliative care providers in areas with fewer services to have rapid access to 
specialist support and advice. Whilst previous evidence referred only to patients with COPD 
and ILD (Irish Thoracic Society et al. 2008), the present study identified the need for these 
services to also filter down to patients with bronchiectasis. 
  
To provide further evidence regarding the reasons for patients and carers lack of awareness 
regarding the life-limiting nature of NMRD, future research could explore the quality of 
palliative and end of life discussions with patients with NMRD and their carers. Previous 
research has explored these discussions with patients with COPD (Leung et 
al. 2012), however further investigation amongst patients with ILD and bronchiectasis, 
alongside COPD, that also includes the carer is warranted. A quantitative study that aims to 
investigate the quality of palliative and end of life care discussions between HCPs and 
patients with NMRD and their carers, through the previously validated Quality of 
Communication Tool (Curtis et al. 2008) could be conducted. 
 
 
Limitations 
Eighteen HCPs were recruited into the study however the majority who participated were 
nurses (n=13). Increased numbers of allied HCPs and medical staff may have provided more 
diverse perspectives. The majority of carers who participated in the study (n=17) had cared 
for someone with COPD (n=12) and only a small number of participants had cared for 
someone with ILD (n=4) or bronchiectasis (n=1). Recruiting greater numbers from the other 
two disease groups may have provided further perspectives. Findings also only represented 
the perspectives of carers and HCPs and not the patient’s own perspective. 
  
CONCLUSION 
This study illuminated the challenges patients, carers and HCPs encountered due to the 
uncertain NMRD trajectory and how this had an impact on death preparedness and the receipt 
of palliative care. The availability and coordination of specialist and generalist palliative care 
services for patients with NMRD is fragmented and varied dependant on geographical 
location. Enhanced availability of these services would afford HCPs in areas with fewer 
services to have rapid access to specialist support and advice. To reduce inequalities in the 
provision of palliative care for NMRD, related to geographical location, service development 
measures must be put in place that are inclusive of patients with ILD and bronchiectasis. The 
management of patients with NMRD is complex and challenging with a clear need for a 
stronger and more integrative model of practice, incorporating palliative care in a responsive 
and dynamic way. 
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Table 1: Participant Profiles 
Participants of the semi-structured interviews 
Gender  Women: 14 bereaved carers 
Men: 3 bereaved carers 
Age  Mean: 58.2 years 
Median: 55 years 
Range:  41 – 81 years 
Relation to patient   Daughter  (n=5) 
Son (n=2) 
Wife (n=7) 
Partner (n=1) 
Daughter in-law (n=1) 
Nephew (n=1) 
Patient and carer living 
together 
Yes (n=10) 
No (n=7) 
Occupation  Residential home manager (n=1) 
Unemployed (n=3) 
Retired (n=6) 
Classroom Assistant (n=1) 
Housewife (n=3) 
Probation Officer (n=1) 
Porter (n=1) 
Health and Safety Officer (n=1) 
Time post bereavement  Mean: 7 months 
Median: 6 months 
Range: 4 – 17 months 
Area  Northern Ireland (n=10) 
Republic of Ireland (n=7) 
Rural (n=8) 
Urban (n=9) 
Diagnosis  COPD (n=12) 
Interstitial Lung Disease (n= 4) 
Bronchiectasis (n=1) 
Interview Type  Face to Face (n= 10) 
Telephone (n=7) 
Participants of the Focus Groups 
Occupation  Specialist Palliative Care Occupational Therapist (n=1) 
Respiratory Nurse Specialist (n= 6) 
Palliative Care Nurse Specialist (n= 3) 
Consultant in Palliative Medicine (n= 1) 
Specialist Palliative Care Nurse Consultant (n= 1) 
Respiratory Consultant (n=2) 
Respiratory Ward Manager (n= 1) 
Respiratory Deputy Ward Manager (n= 1) 
Palliative Care Inpatient Unit Deputy Ward manager (n=1) 
Physiotherapist (n= 1) 
Area  Northern Ireland (n=11) 
Republic of Ireland (n= 7) 
Rural (n= 8) 
Urban (n= 10) 
  
 
 
 
 
 
 
 
Figure 1: Flowchart of Recruitment and Retention for Semi-Structured Interviews 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total potential participants identified by gatekeepers (n=30) 
Envelopes containing documents outlined in section 3.5 distributed by gatekeepers 
to potential participants (n=30) 
No Reply (n=8) Consented to being 
contacted by the 
researcher (n=17) 
 
Declined to be 
contacted by the 
researcher (n=5) 
 
No Further 
Involvement 
Telephone contact 
made by the 
researcher 
No further 
Involvement 
Agreed to participate 
in telephone 
interview (n=7) 
Agreed to participate 
in face-to-face 
interview (n=10) 
Not required as 
data saturation 
(n=0) 
Face-to-face 
interviews conducted 
(n=10) 
Interviews 
Cancelled (n=0) 
Telephone interviews 
conducted (n=7) 
Interview arranged, 
informed consent 
obtained 
 
Figure 2: Flowchart of Recruitment and Retention for Focus Groups 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total potential participants identified by gatekeepers (n=25) 
Envelopes containing documents outlined in section 3.6 distributed by gatekeepers 
to potential participants (n=25) 
Declined to be 
contacted by the 
researcher (n=1) 
 
No Reply (n=6) Consented to being contacted by the 
researcher (n=18) 
 
No further 
Involvement 
No Further 
Involvement 
Telephone contact 
made by the 
researcher 
Agreed to participate 
in focus group 
(n=18) 
Focus group 
scheduled, informed 
consent obtained 
4 focus groups 
conducted (n=6; 
n=5; n=3; n=4) 
Supplementary Table 1: Interview Guide 
Opening Statement 
Can you tell me about the care your relative received towards their end of life? 
Topic Areas to Be Covered (Prompts in brackets) 
1.      One area I would like to talk about is what services and support did your relative 
experience from the health care profession in their last year of life? (What, who, 
efficiency, sufficiency, any further needed) 
  
2.      Another area I wish to discuss is what services and support did you experience 
from the healthcare profession while caring for your relative in their last year of 
life? (What, who, efficiency, sufficiency, any further needed) 
  
3.      I would like to discuss the symptoms your relative experienced in their last year of 
life and how these symptoms were managed. (Sufficiency of information, staff 
knowledge and expertise, quality of symptom management, emergency contacts for 
symptom management) 
  
4.      Can you tell me about when and where your relative died and if you felt this was 
their preferred place to die. (why they died here, anything further could have been 
done to facilitate preferred place to die) 
  
5.      Can you tell me about what support you received after the death of your relative, if 
any, and how did you feel about this support? 
  
6.       Thinking about your experience caring for your relative, do you think there was 
any service or support that could have been provided that would have been 
beneficial for you or your relative? 
  
  
  
 
  
  
       
 
 
 
 
 
 
 
 
Supplementary Table 2: Focus Group Topic Guide 
1.      To start, could anyone tell me about the palliative health care provision that is 
currently available for people with non- malignant respiratory disease and their 
carers, both specialist and generalist? 
2.      What do you feel would make for a high standard of pall care post discharge for 
these patients and carers? 
3.      Can you tell me how well generalist palliative care and specialist palliative care 
services are organized and resourced both in the hospital and community setting? 
4.      Can you tell me how effective are the lines of communication between the HCPs 
involved? (Especially between generalist palliative care and specialist palliative 
care ) 
5.      Can you tell me how well generalist palliative care and specialist palliative care 
services are accessed by this client group both in the hospital and community 
setting? 
6.      How do you perceive patients and their carers understand of the meaning of 
palliative care? 
7.      What do you perceive as good palliative care? 
8.      What are the barriers and facilitators of good palliative care? 
9.      Any suggestions for improvement? 
10.  How do you feel good generalist palliative care compares with specialist palliative 
care? 
11.  How do you perceive the generalist palliative careand specialist palliative care 
services available to patients with a diagnosis of either bronchiectasis or interstitial 
lung disease (ILD) and their carers, compares to the services available to those with 
a diagnosis of COPD? 
12.  How do you perceive the generalist palliative care and specialist palliative care 
services available to NMRD patients and their carers in rural areas compares to the 
services available to those in urban areas? 
13.  Can you tell me about any Models of Palliative Care that are used at present to 
guide the provision of palliative care? 
14.  How do you perceive the role of the Healthcare Support Worker in delivering 
palliative care to patients at home? 
15.  Can you tell me how you perceive how generalist palliative care and specialist 
palliative care providers communicate with NMRD patients and their carers? 
16.  Can you tell me your perceptions about how the information needs of carers and 
patients are met? 
17.  Can you tell me about the barriers and facilitators in relation to communicating 
with patients and carers? 
18.  Can you tell me how you feel about how effective discussions around end-of-life 
and prognosis with patients and carers are? 
19.  What are the barriers involved in having these conversations? 
20.  Any suggestions for improvement? 
21.  How effective do you feel HCPs are at taking into consideration the wishes of the 
patient and their family? 
  
  
Supplementary Table 3: Overarching and Interpretative Themes 
Bereaved Carers’ Interview Findings 
Overarching Themes  Interpretative Themes 
1.      Lack of 
preparedness 
for death 
1 (a) Uncertainty related to unpredictability of disease 
1 (b) “We were never told they were nearing the end of their life.” 
2.      Lack of 
consistency in 
palliative care 
delivery 
2 (a) “I would have liked them to have been more involved.” 
2 (b) Generalist palliative care in Northern Ireland 
3.      Role 
Ambiguity 
3 (a) Carer felt excluded from elements of the patients care 
3 (b) HCPs depend on the carer 
Healthcare Professionals’ Focus Group Findings 
Overarching Themes  Interpretative Themes 
1. Barriers to 
providing appropriate 
palliative care 
1 (a) Lack of prognostic certainty 
1 (b) Lack of understanding of the role of palliative care in relation to patien
withNMRD 
1 (c) Lack of referral for specialist palliative care for other NMRDs 
1 (d) Lack of services due to geographical location 
2. The future direction 
of palliative care for 
patients with NMRD 
2 (a) Who will provide palliative care 
2 (b) “You have to take the carers on board as well” 
  
  
 
 
      
 
 
 
 
 
 
      
  
 
 
 
 
